Do endogenous volatile organic chemicals measured in breath reflect and maintain CYP2E1 levels in vivo?

Toxicology and Applied Pharmacology

Volumn 146, Issue 2, 1997, Pages 255-260

  Mathews, James M ^a   Raymer, James H ^a   Etheridge, Amy S ^a   Velez, George R ^a   Bucher, John R ^b  

^a RTI INTERNATIONAL   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DICHLOROETHYLENE; CYTOCHROME P450 ISOENZYME; VOLATILE ORGANIC COMPOUND;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREATH ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; LIVER MICROSOME; MALE; NONHUMAN; RAT;

EID: 0030727610     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8257     Document Type: Article

References (33)

1. Allerheiligen S. R. B., Ludden T. M., Burk R. F. The pharmacokinetics of pentane, a by-product of lipid peroxidation. Drug Metab. Dispos. 15:1987;794-800.
2. Andersen M. E., Gargas M. L., Clewell H. J. III. Suicide inactivation of microsomal oxidation by cis- and trans-dichloroethylene in male Fischer rats in vivo. Toxicologist. 6:1986;12.
3. Andersen M. E., Clewell H. J. III, Mahle D. A., Gearhart J. M. Gas uptake studies of deuterium isotope effects on dichloromethane metabolism in female B6C3F1 micein vivo. Toxicol. Appl. Pharmacol. 128:1994;158-165.
4. Asakawa T., Matsushita S. Coloring conditions of thiobarbituric acid test for detecting lipid hydroperoxides. Lipids. 15:1980;137-140.
5. Brady J. F., Li D., Ishizaki H., Lee M., Ning S. M., Xiao F., Yang C. S. Induction of cytochromes P450IIE1 and P450IIB1 by secondary ketones and the role of P450IIE1 in chloroform metabolism. Toxicol. Appl. Pharmacol. 100:1989;342-349.
6. Filser J. G., Bolt H. M., Kimmich K., Bencsath F. A. Exhalation of acetone by rats on exposure totrans. Toxicol. Lett. 2:1978;247-252.
7. Frank H., Hintze T., Bimboes D., Remmer H. Monitoring lipid peroxidation by breath analysis: Endogenous hydrocarbons and their metabolic elimination. Toxicol. Appl. Pharmacol. 56:1980;337-344.
8. Frankel E. N. Volatile lipid oxidation products. Prog. Lipid Res. 22:1982;1-33.
9. Gargas M. L., Clewell H. J. III, Andersen M. E. Gas uptake inhalation techniques and the rates of metabolism of chloromethanes, chloroethanes, and chloroethylenes in the rat. Inhal. Toxicol. 2:1990;295-319.
10. Gonzalez F. J., Gelboin H. V. Roles of cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab. Rev. 26:1994;165-184.
11. Gorski J. C., Jones D. R., Wrighton S. A., Hall S. D. Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone. Xenobiotica. 27:1997;243-256.
12. Guengerich F. P., Kim D.-H., Iwasaki M. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4:1991;168-179.
13. Johansson I., Ekstrom G., Scholte B., Puzycki D., Jornvall H., Ingelman-Sundberg M. Ethanol-, fasting- and acetone-inducible cytochromes P-450 in rat liver: Regulation and characteristics of enzymes belonging to the IIB and IIE gene subfamilies. Biochemistry. 27:1988;1925-1934.
14. Kato S., Sheilds P. G., Caporaso N. E., Sugimura H., Trivers G. E., Tucker M. A., Trump B. F., Weston A., Harris C. C. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer. Cancer Epidemiol. Biomarkers Prev. 3:1994;515-518.
15. Kim R. B., O'Shea D. Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clin. Pharmacol. Ther. 57:1995;645-655.
16. Kim R. B., Yamazaki H., Chiba K., O'Shea D., Mimura M., Guengerich F. P., Ishizaki T., Shimada T., Wilkinson G. R. In vivoin vitro. J. Pharmacol. Exp. Ther. 279:1996;4-11.
17. 1414. Dev. Pharmacol. Ther. 16:1991;164-175.
18. Kurata N., Hurst H. E., Benz F. W., Kemper R. A., Waddell W. J. Studies on inhibition and induction of metabolism of ethyl carbamate by acetone and related compounds. Evidence for metabolism by cytochromes P-450. Drug Metab. Dispos. 19:1991;388-393.
19. Lee S. S. T., Buters J. T. M., Pineau T., Fernandez-Salguero P., Gonzalez F. J. Role of CYP2E1 in the hepatotoxicity of acetaminophen. J. Biol. Chem. 271:1996;12063-12067.
20. Mathews J. M., Raymer J. H., Velez G. R., Garner C. E., Bucher J. R. The influence of cytochrome P450 enzyme activity on the composition and quantity of volatile organics expired in breath. Biomarkers. 1:1996;196-201.
21. Mathews J. M., Raymer J. H., Velez G. R., Etheridge A. E., Bucher J. R. Cytochrome P-450 2E1 modulates the composition and quantity of volatile components in breath. ISSX Proc. 8:1995;74.
22. Med. Lett. Drugs Ther. 38:1996;46.
23. Nakajima T., Elovaara E., Okino T., Gelboin H. V., Klockars M., Riihimaki V., Aoyama T., Vainio H. Different contributions of cytochrome P450 2E1 and P450 2B1/2 to chloroform hepatotoxicity in rat. Toxicol. Appl. Pharmacol. 133:1995;215-222.
24. Raymer J. H., Slauter R. W., Velez G. R., Gaudette N., Bucher J. R. A non-rebreathing breath collection system for the study of exogenous and endogenous compounds in the Fischer-344 rat. Toxicol. Methods. 4:1994;243-258.
25. Roberts B. J., Song B.-J., Soh Y., Park S. S., Shoaf S. E. Ethanol induces CYP2E1 by protein stabilization. J. Biol. Chem. 270:1995;29632-29635.
26. Ronis M. J. J., Lindros K. O., Ingelman-Sundberg. The cytochrome P4502E subfamily. Cytochromes P450, Pharmacological and Toxicological Aspects. 1996;CRC Press, Boca Raton. p. 211-239.
27. Schenkman J. B., Thummel K. E., Favreau L. V. Physiological and pathophysiological alterations in rat hepatic cytochrome P-450. Drug Metab. Rev. 20:1989;557-584.
28. Song B.-J., Veech R. L., Park S. S., Gelboin H. V., Gonzalez F. J. Induction of rat hepatic N-nitrosodimethylamine demethylase by acetone is due to protein stabilization. J. Biol. Chem. 264:1989;3568-3572.
29. Stephens E. A., Taylor J. A., Kaplan N., Yang C.-H., Hsieh L. L., Lucier G. W., Bell D. A. Ethnic variation in the CYP2E1 gene: Polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese. Pharmacogenetics. 4:1994;185-192.
30. Thornton-Manning J. R., Lilly P. D., Andersen M. E. Inhibition of CYP2E1 in rat liver microsomes by dichloroethylene isomers. Toxicologist. 14:1994;54.
31. Tindberg N., Ingelman-Sundberg M. Cytochrome P-450 and oxygen toxicity. Oxygen-dependent induction of ethanol-inducible cytochrome P-450 (IIE1) in rat liver and lung. Biochemistry. 28:1989;4499-4504.
32. Wade C. R., van Rij A. M. In vivo. Anal. Biochem. 150:1985;1-7.
33. Watkins P. B., Murray S. A., Winkelman L. G., Heuman D. M., Wrighton S. A., Guzelian P. S. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P450, studies in rats and patients. J. Clin. Invest. 83:1989;688-697.